Mario Airoldi

4.8k total citations
142 papers, 1.9k citations indexed

About

Mario Airoldi is a scholar working on Oncology, Surgery and Otorhinolaryngology. According to data from OpenAlex, Mario Airoldi has authored 142 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 57 papers in Surgery and 52 papers in Otorhinolaryngology. Recurrent topics in Mario Airoldi's work include Head and Neck Cancer Studies (51 papers), Cancer Treatment and Pharmacology (25 papers) and Head and Neck Surgical Oncology (22 papers). Mario Airoldi is often cited by papers focused on Head and Neck Cancer Studies (51 papers), Cancer Treatment and Pharmacology (25 papers) and Head and Neck Surgical Oncology (22 papers). Mario Airoldi collaborates with scholars based in Italy, Switzerland and United States. Mario Airoldi's co-authors include Fulvia Pedani, C. Bumma, Giovanni Succo, P. Gabriele, Sara Marchionatti, Anna Maria Gabriele, Luigi Cattel, Giancarlo Pecorari, Riccardo Ragona and Carlo Giordano and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mario Airoldi

129 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Airoldi Italy 24 1.0k 878 615 498 224 142 1.9k
Katja Lindel Germany 22 708 0.7× 610 0.7× 471 0.8× 466 0.9× 374 1.7× 60 1.9k
Rohini Hawaldar India 19 1.1k 1.1× 866 1.0× 703 1.1× 419 0.8× 648 2.9× 55 2.4k
Daniela Musio Italy 26 941 0.9× 585 0.7× 286 0.5× 685 1.4× 195 0.9× 129 2.1k
M. Gapany United States 22 698 0.7× 657 0.7× 652 1.1× 370 0.7× 153 0.7× 265 1.9k
Silke Tribius Germany 27 773 0.8× 861 1.0× 882 1.4× 490 1.0× 388 1.7× 83 2.1k
Salvatore Alfieri Italy 20 930 0.9× 517 0.6× 392 0.6× 417 0.8× 120 0.5× 93 1.6k
Eliezer Robinson Israel 29 924 0.9× 481 0.5× 178 0.3× 819 1.6× 261 1.2× 113 2.4k
Antonio Antón Spain 21 1.4k 1.4× 339 0.4× 289 0.5× 1.0k 2.1× 451 2.0× 61 2.1k
John Hay Canada 23 906 0.9× 1.1k 1.3× 1.3k 2.0× 948 1.9× 125 0.6× 58 2.4k
Guus Hart Netherlands 23 555 0.6× 429 0.5× 193 0.3× 554 1.1× 284 1.3× 44 1.5k

Countries citing papers authored by Mario Airoldi

Since Specialization
Citations

This map shows the geographic impact of Mario Airoldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Airoldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Airoldi more than expected).

Fields of papers citing papers by Mario Airoldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Airoldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Airoldi. The network helps show where Mario Airoldi may publish in the future.

Co-authorship network of co-authors of Mario Airoldi

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Airoldi. A scholar is included among the top collaborators of Mario Airoldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Airoldi. Mario Airoldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riva, Giuseppe, Giuseppe Carlo Iorio, Umberto Ricardi, et al.. (2025). Surgery Versus Chemoradiation Therapy for Oropharyngeal Squamous Cell Carcinoma: A Multidimensional Cross-Sectional Study. Diseases. 13(4). 106–106.
2.
3.
Airoldi, Mario, et al.. (2024). Prediction of Oral Cancer Biomarkers by Salivary Proteomics Data. International Journal of Molecular Sciences. 25(20). 11120–11120. 2 indexed citations
4.
5.
Denaro, Nerina, Giovanni Succo, Mario Airoldi, et al.. (2023). The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d′Aosta multidisciplinary team. Critical Reviews in Oncology/Hematology. 185. 103968–103968. 3 indexed citations
6.
Lu, Yen‐Shen, J.M.Y. Chiu, Mario Airoldi, et al.. (2020). 301P Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for alpelisib (ALP)-induced hyperglycemia: A report of 6 cases from SOLAR-1. Annals of Oncology. 31. S363–S363. 3 indexed citations
7.
Garrone, Ornella, Tommaso Giarratano, Andrea Michelotti, et al.. (2020). 290P From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial. Annals of Oncology. 31. S358–S358.
8.
Franco, Pierfrancesco, Francesca Arcadipane, Paolo Strignano, et al.. (2017). Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. Medical Oncology. 34(3). 40–40. 4 indexed citations
9.
Franco, Pierfrancesco, Monica Rampino, Marina Schena, et al.. (2017). Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients. Medical Oncology. 34(2). 30–30. 13 indexed citations
10.
Russi, Elvio, Francesco Moretto, Monica Rampino, et al.. (2015). Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. Critical Reviews in Oncology/Hematology. 96(1). 167–182. 45 indexed citations
11.
12.
Robert, Annie, et al.. (2007). Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature. European Archives of Oto-Rhino-Laryngology. 264(6). 587–594. 27 indexed citations
13.
Airoldi, Mario, et al.. (2006). Gemcitabine and Oxaliplatin in Patients With Metastatic Breast Cancer Resistant to or Pretreated With Both Anthracyclines and Taxanes. American Journal of Clinical Oncology. 29(5). 490–494. 12 indexed citations
14.
Succo, Giovanni, et al.. (2003). Oropharyngeal carcinoma during pregnancy: clinical and psycho-oncological aspects.. PubMed. 23(6). 440–5. 8 indexed citations
15.
Cattel, Luigi, et al.. (2001). A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions. Il Farmaco. 56(10). 779–784. 7 indexed citations
16.
Airoldi, Mario, Antonella De Stefani, Sara Marchionatti, et al.. (2001). Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio‐chemotherapy. Head & Neck. 23(4). 298–304. 8 indexed citations
17.
Stefani, Antonella De, Antonio Usai, Roberto Albera, et al.. (1999). Carcinoma of the larynx in the elderly: Analysis of potentially significant prognostic variables. Aging Clinical and Experimental Research. 11(5). 316–322. 9 indexed citations
18.
Toma, S., Mario Airoldi, Raffaella Palumbo, P Raffo, & C. Bumma. (1997). Combination of alpha-interferon 2a (α-IFN 2a) and 13-CIS-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN). International Journal of Cancer. 70(4). 491–493. 3 indexed citations
19.
Airoldi, Mario, et al.. (1994). Chemotherapy for Recurrent Salivary Gland Malignancies: Experience of the ENT Department of Turin University. ORL. 56(2). 105–111. 16 indexed citations
20.
Orecchia, Roberto, Mario Airoldi, Riccardo Ragona, et al.. (1992). Results of chemotherapy plus external reirradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. European Journal of Cancer Part B Oral Oncology. 28(2). 109–111. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja Lindel Breakdown of academic impact, for papers by Rohini Hawaldar Breakdown of academic impact, for papers by Daniela Musio Breakdown of academic impact, for papers by M. Gapany Breakdown of academic impact, for papers by Silke Tribius Breakdown of academic impact, for papers by Salvatore Alfieri Breakdown of academic impact, for papers by Eliezer Robinson Breakdown of academic impact, for papers by Antonio Antón Breakdown of academic impact, for papers by John Hay Breakdown of academic impact, for papers by Guus Hart
Rankless by CCL
2026